# US 2023/0054166 A1 · Composition, layer including the composition, light-emitting device including the composition, and electronic apparatus including the light-emitting device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0054166 A1
- Document ID: US20230054166A1
- Status: Published application
- Kind: A1
- Application number: 17/837,109
- Filed: 2022-06-10
- Published: 2023-02-23
- Earliest claimed: 2021-06-11
- Assignees: Samsung Electronics Co., Ltd.
- Applicants: Samsung Electronics Co., Ltd.
- Inventors: Kum Hee Lee; Byungjoon Kang; Seungyeon Kwak; Myungsun Sim; Banglin Lee; Sunghun Lee; Jeoungin Yi; Byoungki Choi
- Web page: https://patentgrep.com/patent/US20230054166A1

## CPC

- H10K 85/342: {comprising iridium}
- C07F 15/0033: {Iridium compounds}
- C09K 11/06: containing organic luminescent materials
- H10K 85/40: Organosilicon compounds, e.g. TIPS pentacene
- C09K 2211/1029: containing one nitrogen atom as the heteroatom
- C09K 2211/1048: with oxygen
- C09K 2211/185: of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
- H10K 50/11: characterised by the electroluminescent [EL] layers
- H10K: ORGANIC ELECTRIC SOLID-STATE DEVICES
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE

## Abstract

A composition, including a first compound represented by Formula 1 and a second compound represented by Formula 2: Ir(L11)n11(L12)n12(L13)n13 Formula 1 Ir(L21)n21(L22)n22(L23)n23 Formula 2 wherein L11, L12, L13, L21, L22, and L23 are each i) a bidentate ligand bonded to Ir of Formula 1 or 2 via two nitrogen atoms, ii) a bidentate ligand bonded to Ir of Formula 1 or 2 via a nitrogen atom and a carbon atom, or iii) a bidentate ligand bonded to Ir of Formula 1 or 2 via two carbon atoms, L11, L12, and L13 are different from one another; n11, n12, n21, and n22 are each independently 1 or 2; n13 and n23 are each independently 0 or 1; a sum of n11, n12, and n13 is 3; a sum of n21, n22, and n23 is 3; and L11 and L21 are different from each other.

## Claims

### Claim 1

A composition, comprising a first compound represented by Formula 1 and a second compound represented by Formula 2:
Ir(L11)n11(L12)n12(L13)n13 Formula 1
Ir(L21)n21(L22)n22(L23)n23 Formula 2
wherein, in Formulae 1 and 2,
L11, L12, L13, L21, L22, and L23 are each independently:
i) a bidentate ligand bonded to iridium of Formula 1 via two nitrogen atoms, or a bidentate ligand bonded to iridium of Formula 2 via two nitrogen atoms,
ii) a bidentate ligand bonded to iridium of Formula 1 via a nitrogen atom and a carbon atom, or a bidentate ligand bonded to iridium of Formula 2 via a nitrogen atom and a carbon atom, or
iii) a bidentate ligand bonded to iridium of Formula 1 via two carbon atoms, or a bidentate ligand bonded to iridium of Formula 2 via two carbon atoms,
L11, L12, and L13 are different from one another,
n11 and n12 are each independently 1 or 2,
n13 is 0 or 1,
a sum of n11, n12, and n13 is 3,
L21, L22, and L23 are different from one another,
n21 and n22 are each independently 1 or 2,
n23 is 0 or 1,
a sum of n21, n22, and n23 is 3, and
L11 and L21 are different from each other.

### Claim 2 (depends on 1)

The composition of claim 1, wherein
n13 of Formula 1 is 0, and
n23 of Formula 2 is 0.

### Claim 3 (depends on 1)

The composition of claim 1, wherein
L11 is a ligand represented by Formula 1-1,
L12 is a ligand represented by Formula 1-2,
L13 is a ligand represented by Formula 1-1 or a ligand represented by Formula 1-2,
L21 is a ligand represented by Formula 2-1,
L22 is a ligand represented by Formula 2-2,
L23 is a ligand represented by Formula 2-1 or a ligand represented by Formula 2-2:
wherein, in Formulae 1-1, 1-2, 2-1, and 2-2,
Y1 to Y8 are each independently N or C,
ring A1, ring A2, ring A3, ring A4, ring A5, ring A6, ring A7, and ring A8 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group,
W1 to W8 are each independently a single bond, a C1-C20 alkylene group that is unsubstituted or substituted with at least one R10a, a C5-C30 carbocyclic group that is unsubstituted or substituted with at least one R10a, or a C1-C30 heterocyclic group that is unsubstituted or substituted with at least one R10a,
Z1 to Z8 are each independently hydrogen, deuterium, —F, —Cl, —Br, —I, —SF5, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C2-C60 alkenyl group, a substituted or unsubstituted C2-C60 alkynyl group, a substituted or unsubstituted C1-C60 alkoxy group, a substituted or unsubstituted C1-C60 alkylthio group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C1-C10 heterocycloalkyl group, a substituted or unsubstituted C3-C10 cycloalkenyl group, a substituted or unsubstituted C1-C10 heterocycloalkenyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C7-C60 alkyl aryl group, a substituted or unsubstituted C7-C60 aryl alkyl group, a substituted or unsubstituted C6-C60 aryloxy group, a substituted or unsubstituted C6-C60 arylthio group, a substituted or unsubstituted C1-C60 heteroaryl group, a substituted or unsubstituted C2-C60 alkyl heteroaryl group, a substituted or unsubstituted C2-C60 heteroaryl alkyl group, a substituted or unsubstituted C1-C60 heteroaryloxy group, a substituted or unsubstituted C1-C60 heteroarylthio group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group, —N(Q1)(Q2), —Si(Q3)(Q4)(Q5), —Ge(Q3)(Q4)(Q5), —B(Q6)(Q7), —P(═O)(Q8)(Q), or —P(Q8)(Q),
e1 to e8 and d1 to d8 are each independently an integer from 0 to 20,
one or more of i) two or more of a plurality of Z1(s), ii) two or more of a plurality of Z2(s), iii) two or more of a plurality of Z3(s), iv) two or more of a plurality of Z4(s), v) two or more of a plurality of Z5(s), vi) two or more of a plurality of Z6(s), vii) two or more of a plurality of Z7(s), and viii) two or more of a plurality of Z8(s) are respectively optionally bonded to each other to form a C5-C30 carbocyclic group that is unsubstituted or substituted with at least one R10a or a C1-C30 heterocyclic group that is unsubstituted or substituted with at least one R10a,
R10a is as described in connection with Z1,
* and *′ in Formulae 1-1, 1-2, 2-1, and 2-2 each indicate a binding site to iridium in Formulae 1 and 2,
at least one substituent of the substituted C1-C60 alkyl group, the substituted C2-C60 alkenyl group, the substituted C2-C60 alkynyl group, the substituted C1-C60 alkoxy group, the substituted C1-C60 alkylthio group, the substituted C3-C10 cycloalkyl group, the substituted C1-C10 heterocycloalkyl group, the substituted C3-C10 cycloalkenyl group, the substituted C1-C10 heterocycloalkenyl group, the substituted C6-C60 aryl group, the substituted C7-C60 alkyl aryl group, the substituted C7-C60 aryl alkyl group, the substituted C6-C60 aryloxy group, the substituted C6-C60 arylthio group, the substituted C1-C60 heteroaryl group, the substituted C2-C60 alkyl heteroaryl group, the substituted C2-C60 heteroaryl alkyl group, the substituted C1-C60 heteroaryloxy group, the substituted C2-C60 heteroarylthio group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group is:
deuterium, —F, —Cl, —Br, —I, —CD3, —CD2H, —CDH2, —CF3, —CF2H, —CFH2, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, or a C1-C60 alkylthio group;
a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, or a C1-C60 alkylthio group, each substituted with at least one of deuterium, —F, —Cl, —Br, —I, —CD3, —CD2H, —CDH2, —CF3, —CF2H, —CFH2, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C7-C60 alkyl aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a C2-C60 alkyl heteroaryl group, a C1-C60 heteroaryloxy group, a C1-C60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q11)(Q12), —Si(Q13)(Q14)(Q15), —Ge(Q13)(Q14)(Q15), —B(Q16)(Q17), —P(═O)(Q18)(Q19), —P(Q18)(Q19), or a combination thereof;
a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C7-C60 alkyl aryl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a C2-C60 alkyl heteroaryl group, a C1-C60 heteroaryloxy group, a C1-C60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each unsubstituted or substituted with at least one of deuterium, —F, —Cl, —Br, —I, —CD3, —CD2H, —CDH2, —CF3, —CF2H, —CFH2, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C1-C60 alkylthio group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C7-C60 alkyl aryl group, a C7-C60 aryl alkyl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a C2-C60 alkyl heteroaryl group, a C2-C60 heteroaryl alkyl group, a C1-C60 heteroaryloxy group, a C1-C60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, a monovalent non-aromatic condensed heteropolycyclic group, —N(Q21)(Q22), —Si(Q23)(Q24)(Q25), —Ge(Q23)(Q24)(Q25), —B(Q26)(Q27), —P(═O)(Q28)(Q29), —P(Q28)(Q29), or a combination thereof; or
—N(Q31)(Q32), —Si(Q33)(Q34)(Q35), —Ge(Q33)(Q34)(Q35), —B(Q36)(Q37), —P(═O)(Q38)(Q39), or —P(Q38)(Q39);
and
Q1 to Q9, Q11 to Q19, Q21 to Q29, and Q31 to Q39 are each independently: hydrogen, deuterium, —F, —Cl, —Br, —I, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C1-C60 alkyl group, a C2-C60 alkenyl group, a C2-C60 alkynyl group, a C1-C60 alkoxy group, a C1-C60 alkylthio group, a C3-C10 cycloalkyl group, a C1-C10 heterocycloalkyl group, a C3-C10 cycloalkenyl group, a C1-C10 heterocycloalkenyl group, a C6-C60 aryl group, a C7-C60 alkyl aryl group, a C7-C60 aryl alkyl group, a C6-C60 aryloxy group, a C6-C60 arylthio group, a C1-C60 heteroaryl group, a C2-C60 alkyl heteroaryl group, a C2-C60 heteroaryl alkyl group, a C1-C60 heteroaryloxy group, a C1-C60 heteroarylthio group, a monovalent non-aromatic condensed polycyclic group, or a monovalent non-aromatic condensed heteropolycyclic group, each unsubstituted or substituted with at least one of deuterium, a C1-C60 alkyl group, a C6-C60 aryl group, a C7-C60 alkyl aryl group, a C7-C60 aryl alkyl group, or a combination thereof.

### Claim 4 (depends on 3)

The composition of claim 3, wherein ring A1 and ring A3 are different from each other.

### Claim 5 (depends on 3)

The composition of claim 3, wherein ring a Y3-containing monocyclic group in A3 is a 5-membered ring.

### Claim 6 (depends on 3)

The composition of claim 3, wherein
ring A1 and ring A5 are each independently:
a pyridine group, a pyrimidine group, a pyridazine group, or a pyrazine group; or
a pyridine group, a pyrimidine group, a pyridazine group, or a pyrazine group, each condensed with at least one of a cyclohexane group, a norbornane group, a benzene group, or a combination thereof, and
ring A3 and ring A7 are each independently:
a pyridine group, a pyrimidine group, a pyridazine group, or a pyrazine group;
a pyridine group, a pyrimidine group, a pyridazine group, or a pyrazine group, each condensed with at least one of a cyclohexane group, a norbornane group, a benzene group, or a combination thereof; or
an imidazole group, a benzimidazole group, a naphthoimidazole group, a phenanthrenoimidazole group, a pyridinoimidazole group, an oxazole group, a benzoxazole group, a naphthooxazole group, a phenanthrenooxazole group, a pyridinooxazole group, a thiazole group, a benzothiazole group, a naphthothiazole group, a phenanthrenothiazole group, or a pyridinothiazole group.

### Claim 7 (depends on 3)

The composition of claim 3, wherein ring A2 and ring A4 are different from each other.

### Claim 8 (depends on 3)

The composition of claim 3, wherein ring A6 and ring A8 are different from each other.

### Claim 9 (depends on 3)

The composition of claim 3, wherein
ring A2 and ring A6 are each independently:
a benzene group, a naphthalene group, a phenanthrene group, a dibenzofuran group, a dibenzothiophene group, a dibenzoselenophene group, a carbazole group, a fluorene group, or a dibenzosilole group; or
a benzene group, a naphthalene group, a phenanthrene group, a dibenzofuran group, a dibenzothiophene group, a dibenzoselenophene group, a carbazole group, a fluorene group, or a dibenzosilole group, each condensed with at least one of a cyclohexane group, a norbornane group, a benzene group, or a combination thereof, and
ring A4 and ring A8 are each independently:
a benzene group, a naphthalene group, a phenanthrene group, a dibenzofuran group, a dibenzothiophene group, a dibenzoselenophene group, a carbazole group, a fluorene group, a dibenzosilole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzoselenophene group, an azacarbazole group, an azafluorene group, an azadibenzosilole group or a phenanthrobenzofuran group; or
a benzene group, a naphthalene group, a phenanthrene group, a dibenzofuran group, a dibenzothiophene group, a dibenzoselenophene group, a carbazole group, a fluorene group, a dibenzosilole group, an azadibenzofuran group, an azadibenzothiophene group, an azadibenzoselenophene group, an azacarbazole group, an azafluorene group, or an azadibenzosilole group, each condensed with at least one of a benzene group, a pyridine group, a pyrimidine group, a pyridazine group, a pyrazine group, a cyclohexane group, a norbornane group, a furan group, a thiophene group, a selenophene group, a pyrrole group, a cyclopentadiene group, a silole group, a pyrazole group, an imidazole group, an oxazole group, a thiazole group, an isoxazole group, an isothiazole group, or a combination thereof.

### Claim 10 (depends on 3)

The composition of claim 3, wherein
e1 and d1 are each not 0,
one or more Z1(s) are each independently:
a C1-C20 alkyl group that is unsubstituted or substituted with at least one of deuterium, —F, a phenyl group, or a combination thereof;
—Si(Q3)(Q4)(Q5); or
—Ge(Q3)(Q4)(Q5).

### Claim 11 (depends on 3)

The composition of claim 3, wherein
e5 and d5 are each not 0,
one or more Z5(s) are each independently:
a C1-C20 alkyl group that is unsubstituted or substituted with at least one of deuterium, —F, a phenyl group, or a combination thereof;
—Si(Q3)(Q4)(Q5); or
—Ge(Q3)(Q4)(Q5).

### Claim 12 (depends on 3)

The composition of claim 3, wherein
Y3 in Formula 1-2 and Y7 in Formula 2-2 are each N, and
a group represented by
in Formula 1-2, and a group represented by
in Formula 2-2 are each independently a group represented by one of Formulae NR1 to NR48:
wherein, in Formulae NR1 to NR48,
Y39 is O, S, Se, N—[W3—(Z3)e3], N—[W7—(Z7)e7], C(Z39a)(Z39b), C(Z79a)(Z79b), Si(Z39a)(Z39b), or Si(Z79a)(Z79b),
W3, W7, Z3, Z7, e3, and e7 are respectively as described in claim 3, Z39a and Z39b are respectively as described in connection with Z3 in claim 3, and Z79a and Z79b are respectively as described in connection with Z7 in claim 3,
*′ indicates a binding site to iridium in Formula 1 or 2, and
*″ indicates a binding site to ring A4 or ring A8.

### Claim 13 (depends on 12)

The composition of claim 12, wherein a group represented by
in Formula 1-2 is a group represented by one of Formulae NR30 to NR48, wherein Formulae NR30 to NR48 are as described in claim 12.

### Claim 14 (depends on 3)

The composition of claim 3,
wherein Y2 in Formula 1-1, Y4 in Formula 1-2, Y6 in Formula 2-1, and Y8 in Formula 2-2 are each C, and
a group represented by
in Formula 1-1,
a group represented by
in Formula 1-2,
a group represented by
in Formula 2-1, and
a group represented by
in Formula 2-2 are each independently a group represented by one of Formulae CR1 to CR29:
wherein, in Formulae CR1 to CR29,
Y49 is O, S, Se, N—[W2—(Z2)e2], N—[W4—(Z4)e4], N—[W6—(Z6)e6], N—[W8—(Z8)e8], C(Z29a)(Z29b), C(Z49a)(Z49b), C(Z69a)(Z69b), C(Z89a)(Z89b), Si(Z29a)(Z29b), Si(Z49a)(Z49b), Si(Z69a)(Z69b), or Si(Z89a)(Z89b),
W2, W4, W6, W8, Z2, Z4, Z6, Z8, e2, e4, e6, and e8 are respectively as described in claim 3, Z29a and Z29b are respectively as described in connection with Z2 in claim 3, Z49a and Z49b are respectively as described in connection with Z4 in claim 3, Z69a and Z69b are respectively as described in connection with Z6 in claim 3, and Z89a and Z89b are respectively as described in connection with Z8 in claim 3,
Y21 to Y24 are each independently N or C,
ring A40 is a C5-C30 carbocyclic group or a C1-C30 heterocyclic group,
* indicates a binding site to iridium in Formulae 1 and 2, and
*″ indicates a binding site to ring A1, ring A3, ring A5, and ring A7.

### Claim 15 (depends on 1)

The composition of claim 1, wherein
the first compound emits a first light comprising a first spectrum, and λP(1) is an emission peak wavelength in nanometers of the first spectrum,
the second compound emits a second light comprising a second spectrum, and λP(2) is an emission peak wavelength in nanometers of the second spectrum, and
λP(1) and λP(2) are each 480 nanometers to 580 nanometers.

### Claim 16 (depends on 1)

The composition of claim 1, wherein
the first compound emits a first light comprising a first spectrum, and λP(1) is an emission peak wavelength in nanometers of the first spectrum,
the second compound emits a second light comprising a second spectrum, and λP(2) is an emission peak wavelength in nanometers of the second spectrum, and
an absolute value of a difference between λP(1) and λP(2) is 0 nanometers to 30 nanometers.

### Claim 17 (depends on 1)

A layer, comprising the composition of claim 1.

### Claim 18 (depends on 1)

A light-emitting device, comprising:
a first electrode;
a second electrode; and
an organic layer located between the first electrode and the second electrode,
wherein the organic layer comprises an emission layer, and
wherein the organic layer comprises the composition of claim 1.

### Claim 19 (depends on 18)

The light-emitting device of claim 18, wherein the emission layer comprises the composition.

### Claim 20 (depends on 18)

An electronic apparatus, comprising the light-emitting device of claim 18.
